PILOT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF QUETIAPINE FUMARATE INSTANT-RELEASE (SEROQUEL IR) IN CONTROLLING AGITATION AND AGGRESSIVE SYMPTOMS IN THE ACUTE TREATMENT OF PATIENTS WITH SCHIZOPHRENIA: